GSK3B and Alzheimer disease: As there is a pronounced decrease in AKT/GSK-3β signaling pathway activation in AD models (Magrané et al., 2005; Povellato et al., 2013), we hypothesized that low-dose ionizing radiation modulates cell death through the AKT survival signaling pathway in Aβ42-expressing AD models.